Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Effective and safe treatments are needed for medulloblastoma-;the most common type of cancerous brain tumor in children-;especially for patients whose cancer has spread to the spinal cord.

Related Keywords

United States ,Massachusetts ,American ,Derek Hanson ,Kevin Bielamowicz ,Peter Carmeliet ,Dang Duda ,Genevieve Bergendahl ,Theodorew Laetsch ,Emily Henderson ,William Ferguson ,Jennifer Michlitsch ,Rakeshk Jain ,Jacquelinem Kraveka ,Gisellel Saulnier Sholler ,Matija Snuderl ,Michaels Isakoff ,Jane Trust Foundation ,Isabella Santos Foundation Solid ,Department Of Defense ,National Institutes Of Health ,Rare Tumor Program ,Beat Childhood Cancer Foundation ,Nile Albright Research Foundation ,American Association For Cancer Research ,National Foundation For Cancer Research ,Atrium Health Levine Children Hospital ,Harvard Ludwig Cancer Center ,Clinical Cancer Research ,Atrium Health Levine Children ,Massachusetts General Hospital ,American Association ,Tumor Biology ,Andrew Werk Cook Professor ,Radiation Oncology ,Harvard Medical ,Beat Childhood Cancer Research Consortium ,Levine Children ,David Ebb ,Beat Childhood Cancer ,National Institutes ,National Foundation ,Cancer Research ,Antibody ,Rain ,Dancer ,Clinical Trial ,Brain Tumor ,Fell ,Children ,Education ,Growth Factor ,Healthcare ,Hospital ,Alignant ,Medical School ,Medicine ,Medulloblastoma ,Ncology ,Protein ,Eceptor ,Research ,Herapeutics ,Humor ,